Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Transplantation ofex vivoexpanded endothelial progenitor cells for therapeutic neovascularization
2000 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy
2010 StandoutNobel
Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease
2001 Standout
The world health organization—International society of hypertension blood pressure lowering treatment trialists’ collaboration: Prospective collaborative overviews of major randomized trials of blood pressure-lowering treatments
1999
Coronary artery apoptosis in experimental hypercholesterolemia
1999
Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*
2005
Nitric oxide synthases: regulation and function
2011 Standout
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Vascular dementia
2015 Standout
Effects of angiotensin II on vascular endothelial cells: formation of receptor-mediated reactive nitrogen species
2003
Effects of Antihypertensive Drugs on Endothelial Dysfunction
2002
Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction
2011
A randomized double-blind placebo-controlled trial of the effect of homocysteine-lowering therapy with folic acid on endothelial function in patients with coronary artery disease
2001
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
Assessment and treatment of endothelial dysfunction in humans
1999
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses
2016
Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes
2002 StandoutNobel
Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
2017 Standout
Paracrine and autocrine effects of nitric oxide on myocardial function
2000
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
2006 Standout
Effect of crossing over hypertensive patients from a beta-blocker to an angiotensin receptor antagonist on resistance artery structure and on endothelial function
2002
Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis
2001
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
2000
Improvement in endothelial function by angiotensin converting enzyme inhibition in insulin-dependent diabetes mellitus.
1997
Antihypertensive therapy in type 2 diabetes: implications of the appropriate blood pressure control in diabetes (ABCD) trial
1998
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary Syndromes<SUBTITLE>The MIRACL Study: A Randomized Controlled Trial</SUBTITLE>
2001 Standout
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Trends in Heart Failure Incidence and Survival in a Community-Based Population
2004 Standout
Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors
2006
Factors involved in the maintenance of endothelial function
1998
Angiotensin-Converting Enzyme Inhibitor–Associated Elevations in Serum Creatinine
2000
Myocarditis
2011 Standout
Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease
2000
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
2003 Standout
The Central Role of Endothelial Dysfunction in Cardiorenal Syndrome
2016
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients
2011
Circulating Endothelial Progenitor Cells, Vascular Function, and Cardiovascular Risk
2003 Standout
Promotion of airway anastomotic microvascular regeneration and alleviation of airway ischemia by deferoxamine nanoparticles
2013 StandoutNobel
The Quinapril Ischemic Event Trial (QUIET): evaluation of chronic ace inhibitor therapy in patients with ischemic heart disease and preserved left ventricular function
2001
Anti-ischemic effects of angiotensin- converting enzyme inhibition in hypertension
2001
Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling
2010
Interactions among ACE, kinins and NO
1999
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
2004 Standout
Effect of Exercise on Coronary Endothelial Function in Patients with Coronary Artery Disease
2000
Atherosclerosis
2000 StandoutNature
Cardiac PET Imaging for the Detection and Monitoring of Coronary Artery Disease and Microvascular Health
2010
Endothelial function
2002
Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study
2004 Standout
Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
2015 Standout
Atherosclerosis
2001 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Enhanced atherosclerosis and kidney dysfunction in eNOS–/–Apoe–/– mice are ameliorated by enalapril treatment
2000 StandoutNobel
Role of Endothelial Dysfunction in Coronary Artery Disease and Implications for Therapy
1997
Endothelial Dysfunction: Does It Matter? Is It Reversible?
1997
Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>
2002 Standout
Differential Impact of Blood Pressure–Lowering Drugs on Central Aortic Pressure and Clinical Outcomes
2006 Standout
Endothelial Progenitor Cells and Vascular Biology in Diabetes Mellitus: Current Knowledge and Future Perspectives
2005
Exacerbation of Atherosclerosis by Hypertension
1996
Executive Summary: HFSA 2010 Comprehensive Heart Failure Practice Guideline
2010
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Chronic Heart Failure in the United States
1998
Enhanced endothelial vasoreactivity in endurance-trained older men
1999
Statin-Sensitive Dysregulated AT1 Receptor Function and Density in Hypercholesterolemic Men
1999
Role of Endothelial Dysfunction in Atherosclerosis
2004 Standout
Long-term l -Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans
1998
Comparative Effect of ACE Inhibition and Angiotensin II Type 1 Receptor Antagonism on Bioavailability of Nitric Oxide in Patients With Coronary Artery Disease
2001
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Endothelial Dysfunction
2003 Standout
Diabetes and Endothelial Dysfunction: A Clinical Perspective
2001
Air Pollution and Cardiovascular Disease
2004 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design
1998
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia
2009
Mental Stress Induces Transient Endothelial Dysfunction in Humans
2000
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis
1999
Improvement in endothelial function by angiotensin-converting enzyme inhibition in non–insulin-dependent diabetes mellitus
1999
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Angiotensin-Converting Enzyme Inhibitors
1998
Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
2016
Effect of Enalapril on Endothelial Function in Young Insulin-Dependent Diabetic Patients: A Randomized, Double-Blind Study 11This study was supported by a grant from Merck Sharp and Dohme Ltd., Hertfordshire, England, United Kingdom. Ms. Donald is supported by a grant from the Coronary Artery Disease Research Foundation (CORDA), London, England, United Kingdom.
1998
Long-Term Effects of Cholesterol Lowering and Angiotensin-Converting Enzyme Inhibition on Coronary Atherosclerosis
2000
Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes
1998
Tissue Angiotensin and Pathobiology of Vascular Disease
2001
Acute and Chronic Angiotensin-1 Receptor Antagonism Reverses Endothelial Dysfunction in Atherosclerosis
2000
Vasculoprotective and Cardioprotective Mechanisms of Angiotensin‐Converting Enzyme Inhibition: The Homeostatic Balance Between Angiotensin II and Nitric Oxide
1997
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Insertion-Deletion Polymorphism of the ACE Gene Modulates Reversibility of Endothelial Dysfunction With ACE Inhibition
2000
Blood Pressure Lowering in Type 2 Diabetes
2015
Mice Lacking Endothelial Angiotensin-Converting Enzyme Have a Normal Blood Pressure
2002 StandoutNobel
Correction of Arterial Structure and Endothelial Dysfunction in Human Essential Hypertension by the Angiotensin Receptor Antagonist Losartan
2000
Angiotensin-Converting Enzyme Is Involved in Outside-In Signaling in Endothelial Cells
2003
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Adenoviral transfer of HIF-1α enhances vascular responses to critical limb ischemia in diabetic mice
2009 StandoutNobel
Cholesterol Reduction Rapidly Improves Endothelial Function After Acute Coronary Syndromes
1999
Endothelial dysfunction and peroxynitrite formation are early events in angiotensin‐induced cardiovascular disorders
2000
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
2003 Standout
Treatment of Periodontitis and Endothelial Function
2007 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Michael Klibaner being referenced
Metoprolol Reverses Left Ventricular Remodeling in Patients With Asymptomatic Systolic Dysfunction
2007
Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: Experiences from MERIT-HF
2005
Baseline clinical and angiographic data in the quinapril ischemic event (QUIET) Trial
1996
Efficacy and Safety of Extended Release Metoprolol Succinate in Hypertensive Children 6 to 16 Years of Age: A Clinical Trial Experience
2007
Clinical trial of extended-release felodipine in pediatric essential hypertension
2003
Angiotensin converting enzyme inhibition, with quinapril, improves endothelial vasomotor dysfunction in patients with coronary artery disease: The TREND study (trial on reversing endothelial dysfunction)
1996
Angiotensin-Converting Enzyme Inhibition With Quinapril Improves Endothelial Vasomotor Dysfunction in Patients With Coronary Artery Disease
1996
One-Year Study of Felodipine or Placebo for Stage 1 Isolated Systolic Hypertension
2001